UPL (UPL) had a P/E of 23.9× on 6 Nov 2026, above the industry P/E of 14.4×, and the shares are 34% below their 52-week high. Sales and net profit fell 1.2% and 19% a year over 3 years; its ROCE of 9.9% is the lowest among the 7 largest Agricultural Inputs peers. Debt is 0.83× equity, and its dividend yield is 1.1%. It is a mid-cap company with a market cap of ₹45,214 Cr, ranked 3rd of 72 Agricultural Inputs companies by market cap; the shares fell 28% over the past year.
- ₹523.30
- ₹538.00
- ₹516.80
- ₹526.50
- 32.4 L
Health check
- ReturnsIn line
−28.0% over a year, better than 3 of 7 peers.
- Price tagPricier
P/E 23.9 vs industry 14.4.
- GrowthShrinking
Sales −1.2%, profit −18.6% a year over 3 years.
- ProfitabilityWeak
ROCE 9.9% vs peer median 20.9%.
- Balance sheetFair
Debt 0.83× equity, interest covered 2.1×, Piotroski 8 of 9.
- Red flags5 to check
Return on equity is low at 5.5%.
Mid cap
Defensive
Key metrics
- Market cap
- ₹45,214 Cr
- Mid cap
- P/E
- 23.9
- Industry 14.4
- Price to book
- 1.30
- Peers 4.28
- Dividend yield
- 1.12%
- ROE
- 5.5%
- Peers 16.2%
- ROCE
- 9.9%
- Peers 20.9%
- Debt to equity
- 0.83
- Debt ₹34,240 Cr
- EPS (TTM)
- ₹22.37
- Face value ₹2
- OPM (TTM)
- 20.0%
- Net margin 3.6%
- Sales growth
- −1.3%
- Latest quarter vs a year ago
- Profit growth
- −26.0%
- Latest quarter vs a year ago
- Price to sales
- 0.86
- EV/EBITDA 10.1
Strengths and risks
Strengths
- Positive operating cash flow in each of the last 4 years.
Risks to check
- Return on equity is low at 5.5%.
- Quarterly profit down 26.0% on a year ago.
- Quarterly sales down 1.3% on a year ago.
- P/E of 23.9 against an industry P/E of 14.4.
- 34% below its 52-week high.
About UPL
UPL Limited, together with its subsidiaries, manufactures and sells pesticides, insecticides, and micronutrients in India, Brazil, the United States, the United Kingdom, and internationally. It operates through Crop protection, Seeds & Post-Harvest solutions, and Non-Agro segments. The company offers herbicides, fungicides, insecticides, acaricides, seed treatment, adjuvants, bio-solutions, public health products, fumigants, soil and water technologies,…
- Headquarters
- Mumbai
- Employees
- 12,399
- Sector
- Basic Materials
- ISIN
- INE628A01036
- Website
- upl-ltd.com
Price range
- Avg volume (3M)
- 22.2 L
- 1-year return
- minus 28.0%
- From 52-week high
- minus 34.1%
Analyst consensus
Next results expected around 1 Feb 2027
Peers · Agricultural Inputs
| Company | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| COROMANDELCoromandel International | 1,824.00 | minus 4.00% | 53,724 | 34.5 | 17.0 | 20.9% | 9.4% | 0.11 | 10.2% | minus 12.4% |
| FACTFertilisers and Chemicals Travancore | 750.25 | minus 1.24% | 48,547 | – | 703.5 | 14.2% | 0.0% | 2.95 | 0.0% | minus 15.3% |
| UPLUPL | 534.90 | plus 1.60% | 45,214 | 23.9 | 6.0 | 9.9% | 20.0% | 0.83 | −1.2% | minus 28.0% |
| PIINDPI Industries | 1,735.00 | minus 1.98% | 26,321 | 30.0 | 13.1 | 14.7% | 24.2% | 0.03 | 1.1% | minus 51.9% |
| SUMICHEMSumitomo Chemical India | 328.95 | plus 0.34% | 16,419 | 29.4 | 21.0 | 21.0% | 20.3% | 0.02 | −2.6% | minus 34.4% |
| CHAMBLFERTChambal Fertilizers & Chemicals | 384.70 | minus 0.91% | 15,413 | 8.1 | 5.7 | 21.8% | 13.7% | 0.16 | −9.2% | minus 19.4% |
| BAYERCROPBayer Cropscience | 3,316.30 | plus 0.48% | 14,904 | 20.0 | 15.4 | 27.9% | 16.0% | 0.03 | 3.6% | minus 31.7% |
| PARADEEPParadeep Phosphates | 142.32 | plus 2.51% | 14,780 | 17.4 | 9.4 | 20.7% | 8.6% | 1.38 | 28.8% | minus 17.4% |
| Median of 7 peers | – | −0.91% | 16,419 | 24.7 | 15.4 | 20.9% | 13.7% | 0.11 | 1.1% | −19.4% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|
| 9,216 | – | 12,269 | 18,335 | 10,181 | 11,860 | |
| 7,721 | – | 9,771 | 14,309 | 8,575 | 9,477 | |
| 1,495 | – | 2,498 | 4,026 | 1,606 | 2,383 | |
| 16.2% | – | 20.4% | 22.0% | 15.8% | 20.1% | |
| −17 | – | −179 | 12 | −9 | 78 | |
| 736 | – | 700 | 836 | 759 | 955 | |
| 731 | – | 827 | 915 | 832 | 819 | |
| −201 | – | −121 | −395 | −115 | −72 | |
| −190 | – | 671 | 1,892 | −109 | 615 | |
| 7.4% | – | 27.0% | 31.6% | 33.0% | 26.5% | |
| −88 | – | 396 | 1,061 | 10 | 421 | |
| -1.94 | 6.74 | 4.69 | 12.57 | 0.12 | 4.99 |
Profit & loss
- Sales CAGR 3Y
- −1.2%
- Profit CAGR 3Y
- −18.6%
- EPS CAGR 3Y
- −20.2%
- ROE
- 5.5%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 53,134 | 42,599 | 46,262 | 51,303 | |
| – | minus 19.8% | +8.6% | +10.9% | |
| 41,837 | 38,545 | 39,451 | 40,956 | |
| 11,297 | 4,054 | 6,811 | 10,347 | |
| 21.3% | 9.5% | 14.7% | 20.2% | |
| −330 | 333 | 572 | −431 | |
| 2,984 | 3,378 | 3,232 | 2,853 | |
| 2,547 | 2,763 | 2,750 | 3,244 | |
| −286 | −333 | −572 | −662 | |
| 5,150 | −2,087 | 829 | 3,157 | |
| 14.3% | 10.0% | 1.1% | 29.7% | |
| 3,570 | −1,200 | 897 | 1,922 | |
| – | minus 133.6% | – | +114.3% | |
| 43.92 | -17.45 | 9.62 | 22.32 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 150 | 150 | 159 | 169 | |
| 29,694 | 27,643 | 32,040 | 34,527 | |
| 23,939 | 29,754 | 25,099 | 23,576 | |
| 34,794 | 29,999 | 30,704 | 36,933 | |
| 88,577 | 87,546 | 88,002 | 95,205 | |
| 10,321 | 10,838 | 10,095 | 11,006 | |
| 1,251 | 1,130 | 664 | 1,092 | |
| 597 | 657 | 616 | 811 | |
| 6,173 | 6,356 | 9,907 | 6,696 | |
| 70,235 | 68,565 | 66,720 | 75,600 | |
| 88,577 | 87,546 | 88,002 | 95,205 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 7,751 | 2,321 | 10,151 | 7,855 | |
| −1,490 | −2,478 | −1,840 | −2,362 | |
| −6,227 | 164 | −4,793 | −9,883 | |
| 34 | 7 | 3,518 | −4,390 | |
| −2,360 | −1,995 | −1,695 | −2,406 | |
| 5,391 | 326 | 8,456 | 5,449 | |
| −750 | −749 | −77 | −478 |
Shareholding pattern
- Promoters33.51%
- Public66.49%
| Quarter | Split | Promoters | Public | Promoter change |
|---|---|---|---|---|
| 30 Sep 2026 | 33.51% | 66.49% | 0.00 | |
| 30 Jun 2026 | 33.51% | 66.49% | 0.00 | |
| 31 Mar 2026 | 33.51% | 66.49% | 0.00 | |
| 5 Feb 2026 | 33.51% | 66.49% | plus 0.01 | |
| 31 Dec 2025 | 33.50% | 66.50% | – |
Major shareholders
Filings & events
News
No recent news coverage found.